Lineage Cell Therapeutics, Inc. (TLV:LCTX)
Israel · Delayed Price · Currency is ILS · Price in ILA 341.70
-3.10 (-0.90%)
Jul 17, 2025, 5:24 PM IDT
Lineage Cell Therapeutics Market Cap
Lineage Cell Therapeutics has a market cap or net worth of 736.66 million as of July 18, 2025. Its market cap has increased by 8.59% in one year.
Market Cap
736.66M
Enterprise Value
578.76M
Revenue
35.59M
Ranking
n/a
PE Ratio
n/a
Stock Price
341.70
Market Cap Chart
Since May 1, 1992, Lineage Cell Therapeutics's market cap has increased from 49.45M to 736.66M, an increase of 1,389.73%. That is a compound annual growth rate of 8.47%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 61.63B |
| Danel (Adir Yeoshua) | 2.90B |
| Kamada | 1.47B |
| Bait Bakfar | 1.07B |
| SofWave Medical | 849.64M |
| BrainsWay | 766.86M |
| Novolog (Pharm-Up 1966) | 717.73M |
| Ilex Medical | 671.06M |